Investigator Edmund W. Tai, M.D.

Sutter Health Research Enterprise
701 E. El Camino Real
North Wing, 1st Floor
Mountain View, CA, 94040
(650) 934-7600
taie1@pamf.org

Primary Research Interests

Related Clinical Trials

Adjuvant (AFT-19)

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Investigators: Priya Chakravarthi M.D., M. Dwight Chen M.D., Natalia Colocci M.D., Ph.D., Huan T. Ha M.D., Gillian L. Hsieh M.D., Paula D. Kushlan M.D., David S. Leibowitz M.D., FACP, Kim-Son Nguyen M.D., Albert Pisani M.D., Bryant C. Sheh M.D., Edmund W. Tai M.D., Janet Wang M.D., Derrick Wong M.D., Glenn D. Wong D.O., Irene Wu M.D., Michael C. Wu M.D., Monique de Bruin M.D., MPH

Status: Active, Not Recruiting

Adjuvant (Alliance A081801)

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO

Investigator: Edmund W. Tai M.D.

Status: Active, Recruiting

Adjuvant (Alliance A151216) ALCHEMIST Screening Trial

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Investigator: Edmund W. Tai M.D.

Status: Active, Recruiting

Adjuvant (ECOG E4512)

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment)

Investigator: Edmund W. Tai M.D.

Status: Active, Recruiting

Adjuvant (SWOG S1806)

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Investigator: Edmund W. Tai M.D.

Status: Active, Recruiting

Adjuvant Merkel Cell (ECOG-ACRIN EA6174)

Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer

Investigator: Edmund W. Tai M.D.

Status: Active, Recruiting

HARMONi Study (AK112-301)

Phase 3 Clinical Study of AK112 for NSCLC Patients

Investigators: Kevin Kim MD, Edmund W. Tai M.D.

The Pathfinder 2 Study (Grail)

Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population

Investigators: Roger Ang MD, Deepti Behl MD, Kristie A. Bobolis M.D., Carole Chan-You M.D., Natalia Colocci M.D., Ph.D., Natasha Fine M.D., Mohammad Hararah M.D., Aaron Kinney M.D., Charles McDonnell MD, FACR, Patrick Ogilvie M.D., Sivakumar Reddy M.D., Nitin Rohatgi MD, Barbara Spinelli M.D., Gayle Sutcliffe M.D., Edmund W. Tai M.D.

Status: Active, Recruiting

The Sutter Health Network of Care

Expertise to fit your needs

Check-ups, screenings and sick visits for adults and children.

Expertise and advanced technologies in all areas of medicine.

For serious accidents, injuries and conditions that require immediate medical care.

After-hours, weekend and holiday services.

Convenient walk-in care clinics for your non-urgent health needs.